ATE413184T1 - Behandlung mit kleinen peptiden um eine antifibroseaktivität zu bewirken - Google Patents

Behandlung mit kleinen peptiden um eine antifibroseaktivität zu bewirken

Info

Publication number: ATE413184T1
Authority: AT; Austria
Prior art keywords: fibrosis; phe; tyr; adhesions; mammal
Prior art date: 1999-03-22

Application number

AT00916561T

Other languages

English (en)

Inventor

James Clagett

Original Assignee

Mowycal Lending Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-22

Filing date

2000-03-20

Publication date

2008-11-15

2000-03-20 Application filed by Mowycal Lending Llc filed Critical Mowycal Lending Llc

2008-11-15 Application granted granted Critical

2008-11-15 Publication of ATE413184T1 publication Critical patent/ATE413184T1/de

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
230000000694 effects Effects 0.000 title 2
230000002300 anti-fibrosis Effects 0.000 title 1
102000004196 processed proteins & peptides Human genes 0.000 title 1
206010016654 Fibrosis Diseases 0.000 abstract 5
230000004761 fibrosis Effects 0.000 abstract 4
238000001356 surgical procedure Methods 0.000 abstract 4
241000124008 Mammalia Species 0.000 abstract 2
201000001320 Atherosclerosis Diseases 0.000 abstract 1
241001647372 Chlamydia pneumoniae Species 0.000 abstract 1
241001269524 Dura Species 0.000 abstract 1
GKZIWHRNKRBEOH-HOTGVXAUSA-N Phe-Phe Chemical group C([C@H]([NH3+])C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)C1=CC=CC=C1 GKZIWHRNKRBEOH-HOTGVXAUSA-N 0.000 abstract 1
FSXRLASFHBWESK-HOTGVXAUSA-N Phe-Tyr Chemical group C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 FSXRLASFHBWESK-HOTGVXAUSA-N 0.000 abstract 1
206010060932 Postoperative adhesion Diseases 0.000 abstract 1
CGWAPUBOXJWXMS-HOTGVXAUSA-N Tyr-Phe Chemical group C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 CGWAPUBOXJWXMS-HOTGVXAUSA-N 0.000 abstract 1
238000012084 abdominal surgery Methods 0.000 abstract 1
230000003510 anti-fibrotic effect Effects 0.000 abstract 1
230000001684 chronic effect Effects 0.000 abstract 1
230000007882 cirrhosis Effects 0.000 abstract 1
208000019425 cirrhosis of liver Diseases 0.000 abstract 1
208000029078 coronary artery disease Diseases 0.000 abstract 1
FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Chemical group C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 abstract 1
210000003238 esophagus Anatomy 0.000 abstract 1
206010061989 glomerulosclerosis Diseases 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
208000014674 injury Diseases 0.000 abstract 1
210000000936 intestine Anatomy 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
210000005036 nerve Anatomy 0.000 abstract 1
210000003101 oviduct Anatomy 0.000 abstract 1
231100000915 pathological change Toxicity 0.000 abstract 1
230000036285 pathological change Effects 0.000 abstract 1
210000000578 peripheral nerve Anatomy 0.000 abstract 1
108010073025 phenylalanylphenylalanine Chemical group 0.000 abstract 1
230000002980 postoperative effect Effects 0.000 abstract 1
208000005069 pulmonary fibrosis Diseases 0.000 abstract 1
230000001954 sterilising effect Effects 0.000 abstract 1
238000004659 sterilization and disinfection Methods 0.000 abstract 1
210000002435 tendon Anatomy 0.000 abstract 1
230000008733 trauma Effects 0.000 abstract 1
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 abstract 1
210000003708 urethra Anatomy 0.000 abstract 1
210000001177 vas deferen Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Neurology (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Surgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT00916561T 1999-03-22 2000-03-20 Behandlung mit kleinen peptiden um eine antifibroseaktivität zu bewirken ATE413184T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US12551499P	1999-03-22	1999-03-22

Publications (1)

Publication Number	Publication Date
ATE413184T1 true ATE413184T1 (de)	2008-11-15

Family

ID=22420066

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00916561T ATE413184T1 (de)	1999-03-22	2000-03-20	Behandlung mit kleinen peptiden um eine antifibroseaktivität zu bewirken

Country Status (18)

Country	Link
US (1)	US20020072499A1 (de)
EP (1)	EP1162990B1 (de)
JP (2)	JP4021147B2 (de)
KR (1)	KR100699509B1 (de)
CN (1)	CN1348381A (de)
AT (1)	ATE413184T1 (de)
AU (1)	AU3765100A (de)
BR (1)	BR0009226A (de)
CA (1)	CA2367048A1 (de)
DE (1)	DE60040730D1 (de)
EA (1)	EA200100997A1 (de)
ES (1)	ES2316359T3 (de)
HK (1)	HK1045649A1 (de)
IL (1)	IL145490A0 (de)
MX (1)	MXPA01009504A (de)
NO (1)	NO20014594L (de)
PL (1)	PL203758B1 (de)
WO (1)	WO2000056349A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7604633B2 (en)	1996-04-12	2009-10-20	Cytyc Corporation	Moisture transport system for contact electrocoagulation
US8551082B2 (en)	1998-05-08	2013-10-08	Cytyc Surgical Products	Radio-frequency generator for powering an ablation device
BR0012495A (pt) *	1999-07-16	2002-06-11	Histatek Llc	Métodos para o tratamento de uma indicação resultante de uma resposta mediada por ige em um mamìfero, para a regulação descendente de um receptor para ige e de ligante cd40, e, para a inibição da secreção de ige por plasmócitos
US7731712B2 (en)	2004-12-20	2010-06-08	Cytyc Corporation	Method and system for transcervical tubal occlusion
US7674260B2 (en) *	2005-04-28	2010-03-09	Cytyc Corporation	Emergency hemostasis device utilizing energy
US8486060B2 (en)	2006-09-18	2013-07-16	Cytyc Corporation	Power ramping during RF ablation
US7846160B2 (en)	2006-12-21	2010-12-07	Cytyc Corporation	Method and apparatus for sterilization
RU2366369C1 (ru) *	2008-04-23	2009-09-10	Государственное учреждение Научный центр реконструктивной и восстановительной хирургии Восточно-Сибирского научного центра Сибирского отделения Российской Академии медицинских наук	Способ микрохирургической декомпрессии большеберцового нерва при тарзальном тоннельном синдроме у больных сахарным диабетом
CN114463249B (zh) *	2021-11-24	2024-04-05	杭州医派智能科技有限公司	一种基于深度学习的用于评估肾小球周围组织纤维化的辅助方法、计算机设备

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2002516820A (ja) *	1997-11-13	2002-06-11	ヒスタテク・エルエルシー	低分子量ペプチド及び喘息及び炎症の治療方法

2000
- 2000-03-20 AT AT00916561T patent/ATE413184T1/de active
- 2000-03-20 IL IL14549000A patent/IL145490A0/xx unknown
- 2000-03-20 ES ES00916561T patent/ES2316359T3/es not_active Expired - Lifetime
- 2000-03-20 WO PCT/US2000/007411 patent/WO2000056349A1/en not_active Ceased
- 2000-03-20 MX MXPA01009504A patent/MXPA01009504A/es active IP Right Grant
- 2000-03-20 PL PL350860A patent/PL203758B1/pl not_active IP Right Cessation
- 2000-03-20 EA EA200100997A patent/EA200100997A1/ru unknown
- 2000-03-20 CN CN00806666A patent/CN1348381A/zh active Pending
- 2000-03-20 BR BR0009226-6A patent/BR0009226A/pt not_active Application Discontinuation
- 2000-03-20 EP EP00916561A patent/EP1162990B1/de not_active Expired - Lifetime
- 2000-03-20 HK HK02107077.9A patent/HK1045649A1/zh unknown
- 2000-03-20 JP JP2000606253A patent/JP4021147B2/ja not_active Expired - Fee Related
- 2000-03-20 AU AU37651/00A patent/AU3765100A/en not_active Abandoned
- 2000-03-20 DE DE60040730T patent/DE60040730D1/de not_active Expired - Lifetime
- 2000-03-20 CA CA002367048A patent/CA2367048A1/en not_active Abandoned
- 2000-03-20 KR KR1020017012064A patent/KR100699509B1/ko not_active Expired - Fee Related
2001
- 2001-09-21 NO NO20014594A patent/NO20014594L/no not_active Application Discontinuation
- 2001-09-21 US US09/960,720 patent/US20020072499A1/en not_active Abandoned
2007
- 2007-01-19 JP JP2007009831A patent/JP2007131635A/ja active Pending

Also Published As

Publication number	Publication date
KR100699509B1 (ko)	2007-03-26
NO20014594D0 (no)	2001-09-21
JP2002539270A (ja)	2002-11-19
EA200100997A1 (ru)	2002-02-28
BR0009226A (pt)	2001-12-26
CA2367048A1 (en)	2000-09-28
DE60040730D1 (de)	2008-12-18
PL203758B1 (pl)	2009-11-30
WO2000056349A1 (en)	2000-09-28
NO20014594L (no)	2001-11-21
EP1162990A1 (de)	2001-12-19
JP4021147B2 (ja)	2007-12-12
ES2316359T3 (es)	2009-04-16
MXPA01009504A (es)	2003-08-19
CN1348381A (zh)	2002-05-08
EP1162990A4 (de)	2002-02-06
KR20010109316A (ko)	2001-12-08
US20020072499A1 (en)	2002-06-13
JP2007131635A (ja)	2007-05-31
IL145490A0 (en)	2002-06-30
EP1162990B1 (de)	2008-11-05
HK1045649A1 (zh)	2002-12-06
PL350860A1 (en)	2003-02-10
AU3765100A (en)	2000-10-09

Legal Events

Date

Code

Title

Description

2009-06-15

UEP

Publication of translation of european patent specification

Ref document number: 1162990

Country of ref document: EP

Publication	Publication Date	Title
Dirksen et al.	1998	Bassini repair compared with laparoscopic repair for primary inguinal hernia: a randomised controlled trial
Kazemier et al.	1997	Laparoscopic vs open appendectomy: a randomized clinical trial
Bosscha et al.	1999	Surgical management of severe secondary peritonitis
Poen et al.	2000	A randomized controlled trial of rubber band ligation versus infra-red coagulation in the treatment of internal haemorrhoids
Fayez et al.	1995	The appendix as the cause of chronic lower abdominal pain
DE60040730D1 (de)	2008-12-18	Behandlung mit kleinen peptiden um eine antifibroseaktivität zu bewirken
Marchal et al.	1997	Obturator hernias—report of seven cases
Arrillaga et al.	1996	Laparoscopic patching of crack cocaine-induced perforated...
Wilkinson	1954	Chemotherapy of tuberculosis of bones and joints
Becmeur et al.	2003	Laparoscopic surgery of Morgagni-Larrey hernias: a multicenter study of the Groupe d'Étude en Coeliochirurgie Infantile (GECI)
Roeder	1925	Appendectomy: A Study in Technic
Birchak et al.	2019	Peculiarities of adhesion process prevention following laparoscopic operations in gynecology
Huang et al.	2024	Efficacy and safety of endoscopic super-hemorrhoidal banding for mixed hemorrhoids with prolapse
Margent et al.	1979	Non Lithiasic Acute Cholecystitis After Shock
Garg et al.	2022	Comparison of three port laparoscopic cholecystectomy with four port laparoscopic cholecystectomy
Yakaryılmaz et al.	2006	Erken evre hemoroid tedavisinde infrared koagulasyon ve lastik bant ligasyon
Hamid et al.	2019	Laparoscopic management of urinary tract calculi: uncommon but effective alternative to open surgery in certain situations
RU2680962C1 (ru)	2019-03-01	Способ симультанного оперативного вмешательства при хроническом калькулезном холецистите в сочетании с пупочной грыжей и диастазом прямых мышц живота
Fansler et al.	1954	Treatment of incontinence and other abnormalities following infections of the anal and rectal regions
RU2121305C1 (ru)	1998-11-10	Способ лечения колоноптоза
Bonjer et al.	1998	Laparoscopic appendectomy in The Netherlands
Afzal	2018	" Clinical Outcomes of Laparoscopic Versus Open Appendicectomy" At Al-Ameen Medical College and Hospital, Vijayapur
Britton et al.	1989	168 double J (pigtail) ureteric catheter insertions: a retrospective review
Murshid	2001	Laparoscopic indirect hernia repair: an evaluation of the ring closure technique
Rahman et al.	2017	An experience of open Mesh Hernioplasty under local anaesthesia